Your Location:
Home >
Browse articles >
Mechanism of Zuoguiwan in Inhibiting Osteoclast Activation Induced by Breast Cancer via Regulating p38 MAPK/ERK Signaling Pathway
Updated:2024-12-17
Previous|Next
    • Mechanism of Zuoguiwan in Inhibiting Osteoclast Activation Induced by Breast Cancer via Regulating p38 MAPK/ERK Signaling Pathway

    • “The latest research found that Zuogui Pill can inhibit the activation of osteoclasts induced by breast cancer by activating p38 MAPK/ERK signaling pathway.”
    • FU Jianjiang , MEI Yinlong , MA Junchao , ZHU Xiaocui , WANG Wei , LYU Hong
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 31, Issue 1, Pages: 1-9(2025)
    • DOI: 10.13422/j.cnki.syfjx.20241822     

      CLC:

    Scan QR Code

  •  
  •  
  • AI Introduction

  • Full Text(HTML)

  • Figs( 6 ) Tabs( 9 )

  • References

  • Publication Info

  • Metrics

427

Views

371

Downloads

2

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Anti-metastatic Effect of Zuoguiwan on Breast Cancer Cells and Its Mechanisms of Action
Traditional Chinese Medicine Regulates Related Signaling Pathways to Prevent and Control Breast Cancer and Precancerous Lesions: A Review
Exploring Mechanism of Breast Cancer Prevention by Liuwei Dihuangwan, Erzhiwan and Zuoguiwan Based on Macrophage Phagocytosis
Herbal Textual Research on Bambusae Succus in Famous Classical Formulas
Pinelliae Rhizoma and Its Prescription Compatibility for Depression Treatment: A Review

Related Author

ZOU Le-lan
LIU Hong-ning
LYU Hong
XU Huan-jun
ZHU Xiao-cui
ZHANG Zhou-miao
FU Jian-jiang
ZENG Yifei

Related Institution

Beijing Hospital of Traditional Chinese Medicine,Capital Medical University
Beijing University of Chinese Medicine
Gansu University of Chinese Medicine
Affiliated Hospital of Gansu University of Chinese Medicine
Academy of Chinese Medical Sciences, Henan University of Chinese Medicine